Proteins that block prostate cancer treatment and what patients need to know
Prostate cancer, a common concern among men, faces treatment challenges due to proteins like AR-V7, which can resist hormone therapy. Detecting these proteins early allows doctors to personalize treatment plans, potentially improving outcomes and avoiding ineffective drugs. Scientists are developing targeted drugs to neutralize these proteins, offering hope for more effective and longer-lasting treatments.
Prostate cancer, a common concern among men, faces treatment challenges due to proteins like AR-V7, which can resist hormone therapy. Detecting these proteins early allows doctors to personalize treatment plans, potentially improving outcomes and avoiding ineffective drugs. Scientists are developing targeted drugs to neutralize these proteins, offering hope for more effective and longer-lasting treatments.
